Medicare Enrolled

Dr. Tomasz Stryjewski, MD

Ophthalmology · Boston, MA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Consulting-driven
243 CHARLES ST, Boston, MA 02114
6175733288
In practice since 2013 (13 years)
NPI: 1164860151 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Stryjewski from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Stryjewski? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Stryjewski

Dr. Tomasz Stryjewski is an ophthalmology specialist in Boston, MA, with 13 years of NPI registration. Based on federal Medicare data, Dr. Stryjewski performed 7,996 Medicare services across 2,104 unique beneficiaries.

Between the years covered by Open Payments, Dr. Stryjewski received a total of $10,014 from 17 pharmaceutical and/or device companies across 36 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Stryjewski is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 13 years in practice ▲ Top 9% volume in MA $10,014 industry payments

Medicare Practice Summary

Medicare Utilization ↗
7,996
Medicare services
Top 9% in MA for ophthalmology
2,104
Unique beneficiaries
$117
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~615 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye injection (Vabysmo/faricimab)
An injection of faricimab-svoa, a medication administered in 0.1 mg doses.
3,600 $29 $58
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
1,310 $32 $140
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
845 $94 $366
Aflibercept eye injection (Eylea) 740 $692 $1,900
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
537 $92 $753
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
367 $69 $213
Injection, ranibizumab, 0.1 mg 210 $184 $550
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
136 $30 $243
Bevacizumab injection, 10 mg
Administration of a 10 mg dose of bevacizumab medication via injection.
77 $56 $110
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
72 $109 $438
Unclassified biologic
A biologic product that does not have a specific HCPCS code assigned.
23 $1,769 $2,375
Vitreous removal between lens and retina
This procedure involves the removal of the vitreous fluid located between the lens and the retina of the eye.
16 $726 $2,420
Removal of retinal membrane
A surgical procedure to remove a membrane from the surface of the retina.
13 $925 $3,520
Injection into eye membrane
A procedure involving the injection of a drug or substance into the membrane that covers the eyeball.
13 $41 $494
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
13 $48 $283
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
13 $1 $44
Laser removal of recurring cataract
A laser procedure to remove a recurring cataract within the lens capsule.
11 $277 $993
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$10,014
Total received (2018-2024)
Avg $1,431/year across 7 years
Top 12% in MA for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
17
Companies
36
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,761 (57.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,052 (30.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,200 (12.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$263
2023
$550
2022
$320
2021
$1,200
2020
$1,351
2019
$5,746
2018
$582

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Carl Zeiss Meditec, Inc.
$168
Apellis Pharmaceuticals, Inc.
$36
ABBVIE INC.
$25
Takeda Pharmaceuticals U.S.A., Inc.
$18
Regeneron Healthcare Solutions, Inc.
$17
Top 3 companies account for 86.7% of 2024 payments
All-time payments by company (2018-2024) ›
Alcon Research LLC
$4,410
Novartis Pharmaceuticals Corporation
$1,459
Alimera Sciences, Inc.
$1,230
Regeneron Pharmaceuticals, Inc.
$1,037
Alcon Vision LLC
$716
Alcon Research Ltd
$302
Carl Zeiss Meditec, Inc.
$168
Alcon Laboratories Inc
$156
Beaver-Visitec International, Inc.
$144
Astellas Pharma US Inc
$120
VisionCare Inc.
$72
ABBVIE INC.
$51
Apellis Pharmaceuticals, Inc.
$51
Regeneron Healthcare Solutions, Inc.
$33
Genentech USA, Inc.
$29
Takeda Pharmaceuticals U.S.A., Inc.
$18
EyePoint Pharmaceuticals US, Inc.
$16
Top 3 companies account for 70.9% of all-time payments
Associated products mentioned in payments ›
BEOVU · Centurion · Constellation · ENTYVIO · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · ILUVIEN · Implantable Miniature Telescope (IMT by Dr. Isaac Lipshitz) · LUMIGAN · Syfovre · VERACITY SURGICAL · Vabysmo · YUTIQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (58%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.

Looking for an ophthalmology specialist in Boston?
Compare ophthalmologists in the Boston area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
518
Per 100K population
66.2
County median income
$92,859
Nearest hospital
MASSACHUSETTS GENERAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Stryjewski is a mixed practice specialist, with above-average Medicare volume (top 9% in MA), with consulting-driven industry engagement in the top 12% of MA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Stryjewski experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Stryjewski performed 3,600 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Stryjewski receive payments from pharmaceutical companies?
Yes. Dr. Stryjewski received a total of $10,014 from 17 companies across 36 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Stryjewski's costs compare to other ophthalmologists in Boston?
Dr. Stryjewski's average Medicare payment per service is $117. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Stryjewski) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →